Weight-loss pill on NHS could burst Wegovy’s bubble

A daily weight-loss pill that could hold the key to meeting soaring global demand for treatments is being developed by scientists.Since the launch of Wegovy, a weekly injection and the only one of the new class of weight-loss drugs that delivers a 15 per cent weight loss or more to be approved for use on the NHS, demand from overweight and obese patients has soared. This level of weight loss is crucial for reducing weight-related complications.The drug has transformed its Danish maker, Novo Nordisk, into the largest company in Europe and helped to establish an industry that could be worth $100 billion by 2030.Now the US company Eli Lilly is investigating the effects of orforglipron, which works in the same way


Recommended For You